Utility of MicroRNAs and siRNAs in cervical carcinogenesis

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Díaz González, Sacnite Del Mar ^a   Deas, Jessica ^a   Benítez Boijseauneau, Odelia ^a   Gómez Cerón, Claudia ^a   Bermúdez Morales, Victor Hugo ^a   Rodríguez Dorantes, Mauricio ^b   Pérez Plasencia, Carlos ^c,d   Peralta Zaragoza, Oscar ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^c INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 101; MICRORNA 10B; MICRORNA 125B; MICRORNA 126; MICRORNA 132; MICRORNA 143; MICRORNA 145; MICRORNA 146A; MICRORNA 155; MICRORNA 16; MICRORNA 182; MICRORNA 192; MICRORNA 200A; MICRORNA 205; MICRORNA 20A; MICRORNA 20B; MICRORNA 221; MICRORNA 222; MICRORNA 26A; MICRORNA 29A; MICRORNA 29B; MICRORNA 31; MICRORNA 34A; MICRORNA 375; PROTEIN E6; PROTEIN E7; SMALL INTERFERING RNA; TRANSCRIPTOME; ONCOPROTEIN; RNA;

BIOGENESIS; CELL CYCLE REGULATION; CELL PROLIFERATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE THERAPY; GENETIC REGULATION; GENOMIC INSTABILITY; HISTORY; HUMAN; NONHUMAN; POSTTRANSCRIPTIONAL GENE SILENCING; REVIEW; RNA INTERFERENCE; UTERINE CERVIX CANCER; WART VIRUS; FEMALE; GENETICS; METABOLISM; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; UTERINE CERVIX TUMOR;

HUMAN PAPILLOMAVIRUS;

FEMALE; HUMANS; MICRORNAS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RNA, NEOPLASM; RNA, SMALL INTERFERING; UTERINE CERVICAL NEOPLASMS;

EID: 84927154664     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/374924     Document Type: Review

References (80)

1. J. Cuzick, M. Arbyn, R. Sankaranarayanan et al.,"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries," Vaccine, vol. 26, supplement 10, pp. K29-K41, 2008.
2. A. Szalmas and J. Konya,"Epigenetic alterations in cervical carcinogenesis," Seminars in Cancer Biology, vol. 19, pp. 144-152, 2009.
3. X. Wang, S. Tang, S.-Y. Le et al.,"Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth," PLoS ONE, vol. 3, no. 7, Article ID e2557, 2008.
4. P. M. Pereira, J. P. Marques, A. R. Soares, L. Carreto, and M. A. S. Santos,"Microrna expression variability in human cervical tissues," PLoS ONE, vol. 5, no. 7, Article ID e11780, 2010.
5. Y. Li, F. Wang, J. Xu et al.,"Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29," Journal of Pathology, vol. 224, no. 4, pp. 484-495, 2011.
6. S. M. Wilting, P. J. Snijders, W. Verlaat et al.,"AlteredmicroRNA expression associated with chromosomal changes contributes to cervical carcinogenesis," Oncogene, vol. 32, no. 1, pp. 106-116, 2013.
7. M. Tijsterman, R. F. Ketting, and R. H. A. Plasterk,"The genetics of RNA silencing," Annual Review of Genetics, vol. 36, pp. 489-519, 2002.
8. D. P. Bartel,"MicroRNAs: genomics, biogenesis, mechanism, and function," Cell, vol. 116, no. 2, pp. 281-297, 2004.
9. A. M. Denli, B. B. J. Tops, R. H. A. Plasterk, R. F. Ketting, and G. J. Hannon,"Processing of primary microRNAs by the Microprocessor complex," Nature, vol. 432, no. 7014, pp. 231-235, 2004.
10. R. I. Gregory, K.-P. Yan, G. Amuthan et al.,"The Microprocessor complex mediates the genesis of microRNAs," Nature, vol. 432, no. 7014, pp. 235-240, 2004.
11. M. Landthaler, A. Yalcin, and T. Tuschl,"The human DiGeorge syndrome critical region gene 8 and its D. melanogaster homolog are required for miRNA biogenesis," Current Biology, vol. 14, no. 23, pp. 2162-2167, 2004.
12. M. T. Bohnsack, K. Czaplinski, and D. Görlich,"Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs," RNA, vol. 10, no. 2, pp. 185-191, 2004.
13. R. F. Ketting, S. E. J. Fischer, E. Bernstein, T. Sijen, G. J. Hannon, and R. H. A. Plasterk,"Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans," Genes and Development, vol. 15, no. 20, pp. 2654-2659, 2001.
14. P. Provost, D. Dishart, J. Doucet, D. Frendewey, B. Samuelsson, and O. Rådmark,"Ribonuclease activity and RNA binding of recombinant human Dicer," The EMBO Journal, vol. 21, no. 21, pp. 5864-5874, 2002.
15. R. I. Gregory, T. P. Chendrimada, N. Cooch, and R. Shiekhattar,"Human RISC couples microRNA biogenesis and posttranscriptional gene silencing," Cell, vol. 123, no. 4, pp. 631-640, 2005.
16. J. Martinez, A. Patkaniowska, H. Urlaub, R. Lührmann, and T. Tuschl,"Single-stranded antisense siRNAs guide target RNA cleavage in RNAi," Cell, vol. 110, no. 5, pp. 563-574, 2002.
17. S. M. Hammond, S. Boettcher, A. A. Caudy, R. Kobayashi, and G. J. Hannon,"Argonaute2, a link between genetic and biochemical analyses of RNAi," Science, vol. 293, no. 5532, pp. 1146-1150, 2001.
18. J.-J. Song, S. K. Smith, G. J. Hannon, and L. Joshua-Tor,"Crystal structure of argonaute and its implications for RISC slicer activity," Science, vol. 305, no. 5689, pp. 1434-1437, 2004.
19. F. V. Rivas, N. H. Tolia, J.-J. Song et al.,"PurifiedArgonaute2 and an siRNA form recombinant human RISC," Nature Structural and Molecular Biology, vol. 12, no. 4, pp. 340-349, 2005.
20. B. Haley and P. D. Zamore,"Kinetic analysis of the RNAi enzyme complex," Nature Structural and Molecular Biology, vol. 11, no. 7, pp. 599-606, 2004.
21. T. P. Chendrimada, R. I. Gregory, E. Kumaraswamy et al.,"TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing," Nature, vol. 436, no. 7051, pp. 740-744, 2005.
22. Q. Liu, T. A. Rand, S. Kalidas et al.,"R2D2, a bridge between the initiation and effector steps of the Drosophila RNAi pathway," Science, vol. 301, no. 5641, pp. 1921-1925, 2003.
23. H. Tabara, E. Yigit, H. Siomi, and C. C. Mello,"The dsRNA binding protein RDE-4 interacts with RDE-1, DCR-1, and a DExH-Box helicase to direct RNAi in C. elegans," Cell, vol. 109, no. 7, pp. 861-871, 2002.
24. Y. Lee, K. Jeon, J.-T. Lee, S. Kim, and V. N. Kim,"MicroRNA maturation: stepwise processing and subcellular localization," EMBO Journal, vol. 21, no. 17, pp. 4663-4670, 2002.
25. J. Lu, G. Getz, E. A. Miska et al.,"MicroRNA expression profiles classify human cancers," Nature, vol. 435, no. 7043, pp. 834-838, 2005.
26. M. S. Kumar, J. Lu, K. L. Mercer, T. R. Golub, and T. Jacks,"Impaired microRNA processing enhances cellular transformation and tumorigenesis," Nature Genetics, vol. 39, no. 5, pp. 673-677, 2007.
27. M. Wozniak,"microRNA in the control of stem-like phenotype of cancer cells," Central European Journal of Biology, vol. 8, no. 10, pp. 931-942, 2013.
28. M.-J. Long, F.-X. Wu, P. Li, M. Liu, X. Li, and H. Tang,"MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells," Cancer Letters, vol. 324, no. 2, pp. 186-196, 2012.
29. S. A. Melo and M. Esteller,"Dysregulation of microRNAs in cancer: playing with fire," FEBS Letters, vol. 585, no. 13, pp. 2087-2099, 2011.
30. W. C. McBee Jr., A. S. Gardiner, R. P. Edwards et al.,"MicroRNA analysis in human papillomavirus (HPV)-associated cervical neoplasia and cancer," Journal of Carcinogenesis &Mutagenesis, vol. 2, no. 1, Article ID 1000114, 2011.
31. A. Budhu, J. Ji, and X. W. Wang,"The clinical potential of microRNAs," Journal of Hematology and Oncology, vol. 3, article 37, 2010.
32. G. van de Putte, R. Holm, A. K. Lie, C. G. Tropé, and G. B. Kristensen,"Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis," Gynecologic Oncology, vol. 89, no. 1, pp. 140-147, 2003.
33. J.-H. Li, X. Xiao, Y.-N. Zhang et al.,"MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells," Gynecologic Oncology, vol. 120, no. 1, pp. 145-151, 2011.
34. S. Volinia, G. A. Calin, C.-G. Liu et al.,"A microRNA expression signature of human solid tumors defines cancer gene targets," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257-2261, 2006.
35. S. D. Sekuklu, M. T. A. Donoghue, and C. Spillane,"miR-21 as a key regulator of oncogenic processes," Biochemical Society Transactions, vol. 37, no. 4, pp. 918-925, 2009.
36. T. Papagiannakopoulos, A. Shapiro, and K. S. Kosik,"MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells," Cancer Research, vol. 68, no. 19, pp. 8164-8172, 2008.
37. Y. Hiyoshi, H. Kamohara, R. Karashima et al.,"MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma," Clinical Cancer Research, vol. 15, no. 6, pp. 1915-1922, 2009.
38. T. Moriyama, K. Ohuchida, K. Mizumoto et al.,"MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance," Molecular Cancer Therapeutics, vol. 8, no. 5, pp. 1067-1074, 2009.
39. S. M. Johnson, H. Grosshans, J. Shingara et al.,"RAS is regulated by the let-7 microRNA family," Cell, vol. 120, no. 5, pp. 635-647, 2005.
40. W.-O. Lui, N. Pourmand, B. K. Patterson, and A. Fire,"Patterns of known and novel small RNAs in human cervical cancer," Cancer Research, vol. 67, no. 13, pp. 6031-6043, 2007.
41. C. Clapé, V. Fritz, C. Henriquet et al.,"miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice," PLoS ONE, vol. 4, no. 10, Article IDe7542, 2009.
42. E. K. O. Ng, W. P. Tsang, S. S. M. Ng et al.,"MicroRNA-143 targetsDNA methyltransferases 3A in colorectal cancer," British Journal of Cancer, vol. 101, no. 4, pp. 699-706, 2009.
43. L. Liu, X. Yu, X. Guo et al.,"MiR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2," Molecular Medicine Reports, vol. 5, no. 3, pp. 753-760, 2012.
44. X. Wang and C. Tournier,"Regulation of cellular functions by the ERK5 signalling pathway," Cellular Signalling, vol. 18, no. 6, pp. 753-760, 2006.
45. S. Noguchi, T. Mori, Y. Hoshino et al.,"MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells," Cancer Letters, vol. 307, no. 2, pp. 211-220, 2011.
46. Y. Akao, Y. Nakagawa, Y. Kitade, T. Kinoshita, and T. Naoe,"Downregulation of microRNAs-143 and -145 in B-cell malignancies," Cancer Science, vol. 98, no. 12, pp. 1914-1920, 2007.
47. P. A. Lochhead, R. Gilley, and S. J. Cook,"ERK5 and its role in tumour development," Biochemical Society Transactions, vol. 40, no. 1, pp. 251-256, 2012.
48. J. Zhang, S. Li, Q. Yan et al.,"Interferon-β induced microRNA-129-5p down-regulates HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical cancer cells," PLoS ONE, vol. 8, no. 12, Article ID e81366, 2013.
49. K. H. Vousden and D. P. Lane,"p53 in health and disease," Nature Reviews Molecular Cell Biology, vol. 8, no. 4, pp. 275-283, 2007.
50. T. M. Wise-Draper and S. I. Wells,"Papillomavirus E6 and E7 proteins and their cellular targets," Frontiers in Bioscience, vol. 13, no. 3, pp. 1003-1017, 2008.
51. F. A. Dick and N. J. Dyson,"Three regions of the pRB pocket domain affect its inactivation by human papillomavirus E7 proteins," Journal of Virology, vol. 76, no. 12, pp. 6224-6234, 2002.
52. T. Veldman, X. Liu, H. Yuan, and R. Schlegel,"Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8211-8216, 2003.
53. D. Morandell, A. Kaiser, S. Herold et al.,"The human papillomavirus type 16 E7 oncoprotein targets Myc-interacting zincfinger protein-1," Virology, vol. 422, no. 2, pp. 242-253, 2012.
54. K. A. O'Donnell, E. A. Wentzel, K. I. Zeller, C. V. Dang, and J. T. Mendell,"c-Myc-regulated microRNAs modulate E2F1 expression," Nature, vol. 435, no. 7043, pp. 839-843, 2005.
55. A. Ota, H. Tagawa, S. Karnan et al.,"Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma," Cancer Research, vol. 64, no. 9, pp. 3087-3095, 2004.
56. T.-C. Chang, D. Yu, Y.-S. Lee et al.,"Widespread microRNA repression byMyc contributes to tumorigenesis," Nature Genetics, vol. 40, no. 1, pp. 43-50, 2008.
57. A. Ventura, A. G. Young, M. M. Winslow et al.,"Targeted deletion reveals essential and overlapping functions of themiR-17 through 92 family of miRNA clusters," Cell, vol. 132, no. 5, pp. 875-886, 2008.
58. H.-W. Kang, F. Wang, Q. Wei et al.,"miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells," FEBS Letters, vol. 586, no. 6, pp. 897-904, 2012.
59. N. Wang, Z. Xu, K. Wang, M. Zhu, and Y. Li,"Construction and analysis of regulatory genetic networks in cervical cancer based on involved microRNAs, target genes, transcription factors and host genes," Oncology Letters, vol. 7, no. 4, pp. 1279-1283, 2014.
60. X. Wang, H. K. Wang, J. P. Mccoy et al.,"Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6," RNA, vol. 15, no. 4, pp. 637-647, 2009.
61. T.-C. Chang, E. A. Wentzel, O. A. Kent et al.,"Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis," Molecular Cell, vol. 26, no. 5, pp. 745-752, 2007.
62. Z.-M. Zheng and X. Wang,"Regulation of cellular miRNA expression by human papillomaviruses," Biochimica et Biophysica Acta: Gene Regulatory Mechanisms, vol. 1809, no. 11-12, pp. 668-677, 2011.
63. M. Jiang and J. Milner,"Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference," Oncogene, vol. 21, no. 39, pp. 6041-6048, 2002.
64. M. Yoshinouchi, T. Yamada, M. Kizaki et al.,"In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA," Molecular Therapy, vol. 8, no. 5, pp. 762-768, 2003.
65. J. S. Lea, N. Sunaga, M. Sato et al.,"Silencing of HPV 18 oncoproteins with RNA interference causes growth inhibition of cervical cancer cells," Reproductive Sciences, vol. 14, no. 1, pp. 20-28, 2007.
66. K. Butz, C. Denk, A. Ullmann, M. Scheffner, and F. Hoppe-Seyler,"Induction of apoptosis in human papillomavirus-positive cancer cells by peptide aptamers targeting the viral E6 oncoprotein," Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 12, pp. 6693-6697, 2000.
67. K. Butz, T. Ristriani, A. Hengstermann, C. Denk, M. Scheffner, and F. Hoppe-Seyler,"siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells," Oncogene, vol. 22, no. 38, pp. 5938-5945, 2003.
68. N. Sima, W. Wang, D. Kong et al.,"RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53," Apoptosis, vol. 13, no. 2, pp. 273-281, 2008.
69. R. Koivusalo, E. Krausz, H. Helenius, and S. Hietanen,"Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs," Molecular Pharmacology, vol. 68, no. 2, pp. 372-382, 2005.
70. L. N. Putral, M. J. Bywater, W. Gu et al.,"RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin," Molecular Pharmacology, vol. 68, no. 5, pp. 1311-1319, 2005.
71. M. Jiang, C. P. Rubbi, and J. Milner,"Gel-based application of siRNA to human epithelial cancer cells induces RNAi-dependent apoptosis," Oligonucleotides, vol. 14, no. 4, pp. 239-248, 2004.
72. X.-Y. Niu, Z.-L. Peng, W.-Q. Duan, H. Wang, and P. Wang,"Inhibition of HPV16 E6 oncogene expression by RNA interference in vitro and in vivo," International Journal of Gynecological Cancer, vol. 16, no. 2, pp. 743-751, 2006.
73. T. Fujii, M. Saito, E. Iwasaki et al.,"Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer," International Journal of Oncology, vol. 29, no. 3, pp. 541-548, 2006.
74. W. Gu, L. Putral, and N. McMillan,"siRNA and shRNA as anticancer agents in a cervical cancer model," Methods in Molecular Biology, vol. 442, pp. 159-172, 2008.
75. Y. Naito, T. Yamada, K. Ui-Tei, S. Morishita, and K. Saigo,"siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference," Nucleic Acids Research, vol. 32, pp. W124-W129, 2004.
76. K. Ui-Tei, Y. Naito, F. Takahashi et al.,"Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference," Nucleic Acids Research, vol. 32, no. 3, pp. 936-948, 2004.
77. K. Yamato, T. Yamada, M. Kizaki et al.,"New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer," Cancer Gene Therapy, vol. 15, no. 3, pp. 140-153, 2008.
78. J. Salazar-León, F. Reyes-Román, A. Meneses-Acosta et al.,"Silencing of HPV16 E6 and E7 oncogenic activities by small interference RNA induces autophagy and apoptosis in human cervical cancer cells," Journal of Nucleic Acids Investigation, vol. 2, no. 1, pp. 59-69, 2011.
79. R. Kuner, M. Vogt, H. Sultmann et al.,"Identification of cellular targets for the human papillomavirus E6 and E7 oncogenes by RNA interference and transcriptome analyses," Journal of Molecular Medicine, vol. 85, no. 11, pp. 1253-1262, 2007.
80. W. T. Wang, Y. N. Zhao, J. X. Yan et al.,"Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery," Journal of Hematology & Oncology, vol. 7, no. 1, article 6, 2014.